Interestingly, protein expression of ACADVL did not change in our DIO model, suggesting that acetylation may inhibit ACADVL activity and thus contribute to obesity-mediated metabolic dysfunction that contributes to cardiac remodeling and disease. The gene discussed is ACADVL; the disease is obesity due to melanocortin 4 receptor deficiency.